• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亚洲纤维肌发育不良患者的特征:系统评价与荟萃分析

Characteristics of Asian patients with Fibromuscular Dysplasia: a systematic review and meta-analysis.

作者信息

Wang Weiwei, Xu Jianzhong, Fujimoto Tomotaka, Pouleur Anne-Catherine, Vancraeynest David, Wang Jiguang, Zen Kan, Stoenoiu Maria Simona, Persu Alexandre

机构信息

Division of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium.

Department of Urology, 302 Hospital of China Guizhou Aviation Industry Group, Anshun, Guizhou, China.

出版信息

Hypertens Res. 2025 Jun 10. doi: 10.1038/s41440-025-02248-2.

DOI:10.1038/s41440-025-02248-2
PMID:40494902
Abstract

A significant knowledge gap exists regarding characteristics of fibromuscular dysplasia (FMD) in Asian patients compared to Caucasian populations. This meta-analysis evaluated FMD characteristics in Asia (PROSPERO ID: CRD42024596516). PubMed, EMBASE, Cochrane Library, Web of Science, VIP, CNKI, and Wanfang databases were searched for observational studies after January 1, 2000, focusing on FMD in Asian populations. Twenty-four studies including 1254 Asian participants (1059 Chinese, 134 Japanese, and 61 others) were analyzed. Among Asian FMD patients, 59.0% (95% CI: 54.3-63.5%) were women, and mean age at FMD diagnosis was 28.6 years (26.7-30.6 years). Multifocal FMD was diagnosed in 38.4% (28.5-48.8%) of participants, and multivessel FMD in 12.7% (4.6-23.6%). Aneurysms and dissections were reported in 13.5% (7.8-20.4%) and 9.0% (1.8-19.9%) of participants, respectively. 99.9% (98.6-100.0%) of patients were hypertensive, 7.6% (5.3-10.2%) had a history of stroke and 40.3% (22.2-59.8%) reported headache. Bilateral renal artery involvement was documented in 17.9% (13.5-22.6%) of participants, and renal atrophy in 29.9% (24.4-35.6%). Compared with Japanese patients, Chinese patients were younger (26.2 vs. 36.2 years, P < 0.001). Furthermore, the proportion of women (59.4% vs. 64.3%, P = 0.334), and multifocal FMD (33.4% vs. 51.6%, P = 0.085) tended to be lower in Chinese versus Japanese patients. In conclusion, compared to published data in Caucasian patients, Asian FMD patients were younger, more often men, with focal FMD, and had lower rates of multivessel involvement, aneurysms, and dissections. Similar trends were found both in Chinese and Japanese patients. Our meta-analysis showed that compared to published data in Caucasian patients, Asian patients with FMD were younger, more often men, with focal FMD, and had lower rates of multivessel involvement, aneurysms, and dissections. Similar trends were found both in Chinese and Japanese patients.

摘要

与白种人群相比,亚洲患者纤维肌发育异常(FMD)的特征存在显著的知识空白。本荟萃分析评估了亚洲地区FMD的特征(PROSPERO编号:CRD42024596516)。检索了PubMed、EMBASE、Cochrane图书馆、Web of Science、维普、知网和万方数据库中2000年1月1日之后的观察性研究,重点关注亚洲人群的FMD。分析了24项研究,包括1254名亚洲参与者(1059名中国人、134名日本人以及61名其他国家的人)。在亚洲FMD患者中,59.0%(95%CI:54.3 - 63.5%)为女性,FMD诊断时的平均年龄为28.6岁(26.7 - 30.6岁)。38.4%(28.5 - 48.8%)的参与者被诊断为多灶性FMD,12.7%(4.6 - 23.6%)为多支血管FMD。分别有13.5%(7.8 - 20.4%)和9.0%(1.8 - 19.9%)的参与者报告有动脉瘤和夹层。99.9%(98.6 - 100.0%)的患者患有高血压,7.6%(5.3 - 10.2%)有中风病史,40.3%(22.2 - 59.8%)报告有头痛。17.9%(13.5 - 22.6%)的参与者记录有双侧肾动脉受累,29.9%(24.4 - 35.6%)有肾萎缩。与日本患者相比,中国患者更年轻(26.2岁对36.2岁,P < 0.001)。此外,中国患者中女性比例(59.4%对64.3%,P = 0.334)和多灶性FMD比例(33.4%对51.6%,P = 0.085)往往低于日本患者。总之,与白种人患者的已发表数据相比,亚洲FMD患者更年轻,男性更多,为局灶性FMD,多支血管受累、动脉瘤和夹层的发生率较低。在中国和日本患者中均发现了类似趋势。我们的荟萃分析表明,与白种人患者的已发表数据相比,亚洲FMD患者更年轻

相似文献

1
Characteristics of Asian patients with Fibromuscular Dysplasia: a systematic review and meta-analysis.亚洲纤维肌发育不良患者的特征:系统评价与荟萃分析
Hypertens Res. 2025 Jun 10. doi: 10.1038/s41440-025-02248-2.
2
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
3
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
4
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
5
Full-mouth treatment modalities (within 24 hours) for chronic periodontitis in adults.成人慢性牙周炎的全口治疗模式(24小时内)
Cochrane Database Syst Rev. 2015 Apr 17;2015(4):CD004622. doi: 10.1002/14651858.CD004622.pub3.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块型银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2022 May 23;5(5):CD011535. doi: 10.1002/14651858.CD011535.pub5.
7
Effectiveness of culturally focused interventions in increasing the satisfaction of hospitalized Asian patients: a systematic review.以文化为重点的干预措施对提高住院亚洲患者满意度的有效性:一项系统评价。
JBI Database System Rev Implement Rep. 2016 Aug;14(8):219-56. doi: 10.11124/JBISRIR-2016-003048.
8
Antidepressants for pain management in adults with chronic pain: a network meta-analysis.抗抑郁药治疗成人慢性疼痛的疼痛管理:一项网络荟萃分析。
Health Technol Assess. 2024 Oct;28(62):1-155. doi: 10.3310/MKRT2948.
9
Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.社区居住的老年人跌倒预防干预措施:系统评价和荟萃分析的益处、危害以及患者的价值观和偏好。
Syst Rev. 2024 Nov 26;13(1):289. doi: 10.1186/s13643-024-02681-3.
10
The quantity, quality and findings of network meta-analyses evaluating the effectiveness of GLP-1 RAs for weight loss: a scoping review.评估胰高血糖素样肽-1受体激动剂(GLP-1 RAs)减肥效果的网状Meta分析的数量、质量及结果:一项范围综述
Health Technol Assess. 2025 Jun 25:1-73. doi: 10.3310/SKHT8119.

引用本文的文献

1
Case Report: Endovascular thrombectomy for acute ischemic stroke with bilateral internal carotid artery fibromuscular dysplasia.病例报告:双侧颈内动脉纤维肌发育不良所致急性缺血性卒中的血管内血栓切除术
Front Cardiovasc Med. 2025 Aug 7;12:1583321. doi: 10.3389/fcvm.2025.1583321. eCollection 2025.

本文引用的文献

1
Global incidence and characteristics of spinal cord injury since 2000-2021: a systematic review and meta-analysis.全球 2000 年至 2021 年脊髓损伤的发病率和特征:系统评价和荟萃分析。
BMC Med. 2024 Jul 8;22(1):285. doi: 10.1186/s12916-024-03514-9.
2
Intravascular ultrasound provides additional insights in the hypertensive patients with focal renal artery fibromuscular dysplasia.血管内超声为高血压合并局灶性肾动脉纤维肌性发育不良患者提供了更多的信息。
Hypertens Res. 2023 Jun;46(6):1407-1416. doi: 10.1038/s41440-023-01216-y. Epub 2023 Feb 10.
3
Prevalence and clinical characteristics of renovascular hypertension associated with fibromuscular dysplasia in China.
中国纤维肌性发育不良相关的血管性高血压的患病率和临床特征。
J Hypertens. 2023 Apr 1;41(4):638-647. doi: 10.1097/HJH.0000000000003382. Epub 2023 Jan 31.
4
Outcomes Following the Endovascular Treatment of Renal Artery Stenosis Caused by Fibromuscular Dysplasia: A Systematic Review and Meta-Analysis.纤维肌性发育不良所致肾动脉狭窄血管内治疗的疗效:一项系统评价和荟萃分析
Ann Vasc Surg. 2022 Jan;78:362-372. doi: 10.1016/j.avsg.2021.06.042. Epub 2021 Sep 17.
5
Current progress in clinical, molecular, and genetic aspects of adult fibromuscular dysplasia.成人纤维肌发育不良的临床、分子和遗传方面的最新进展。
Cardiovasc Res. 2022 Jan 7;118(1):65-83. doi: 10.1093/cvr/cvab086.
6
Methodological quality of case series studies: an introduction to the JBI critical appraisal tool.病例系列研究的方法学质量:JBI 批判性评价工具介绍。
JBI Evid Synth. 2020 Oct;18(10):2127-2133. doi: 10.11124/JBISRIR-D-19-00099.
7
A Novel Recurrent Genetic Variant Is Associated With a Dysplasia-Associated Arterial Disease Exhibiting Dissections and Fibromuscular Dysplasia.一种新型的复发性遗传变异与表现为夹层和纤维肌性发育不良的动脉疾病相关。
Arterioscler Thromb Vasc Biol. 2020 Nov;40(11):2686-2699. doi: 10.1161/ATVBAHA.119.313885. Epub 2020 Sep 17.
8
Rare loss-of-function mutations of PTGIR are enriched in fibromuscular dysplasia.PTGIR 的罕见失功能突变在纤维肌发育不良中富集。
Cardiovasc Res. 2021 Mar 21;117(4):1154-1165. doi: 10.1093/cvr/cvaa161.
9
The European/International Fibromuscular Dysplasia Registry and Initiative (FEIRI)-clinical phenotypes and their predictors based on a cohort of 1000 patients.欧洲/国际纤维肌性发育不良注册和倡议(FEIRI)-基于 1000 名患者队列的临床表型及其预测因素。
Cardiovasc Res. 2021 Feb 22;117(3):950-959. doi: 10.1093/cvr/cvaa102.
10
First International Consensus on the diagnosis and management of fibromuscular dysplasia.第一届国际纤维肌发育不良诊断与管理共识会议。
Vasc Med. 2019 Apr;24(2):164-189. doi: 10.1177/1358863X18821816. Epub 2019 Jan 16.